Following positive trial data , retatrutide, a novel peptide treatment for managing non-insulin dependent hyperglycemia , has obtained official approval from UK’s Medicines and Regulatory Agency (MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/